Intec Pharma appoints Jeffrey A. Meckler to board
Mr. Meckler brings to Intec Pharma more than 25 years of life sciences executive experience.
Mr. Meckler spent more than 17 years at Pfizer, where he held leadership positions in corporate strategic planning, acquisitions and business development, market research, manufacturing systems and sales operations analysis.
Most recently, Mr. Meckler was Chief Executive Officer of Cocrystal Pharma, Inc.
Previously, Mr. Meckler was a director of QLT Inc., and initially the principal executive officer during its transformation into an orphan drug company.
He has served on numerous corporate boards and is currently a director of Retrophin, Inc.
Mr. Meckler earned his J.D. from Fordham University School of Law and is admitted to the New York Bar.
Mr. Meckler earned an M.S. in Industrial Administration and a B.S. in Industrial Management from Carnegie Mellon University. ■
LATEST MOVES FROM Israel
- Intec Pharma appoints Jeffrey A. Meckler as CEO
- Foamix Pharmaceuticals names David Domzalski as CEO
- Compugen appoints Michal Preminger as director
- Alcobra appoints David Baker as interim CEO
- BSD Crown appoints Joseph Williger as active chairman
More inside POST
The best moment to ask for a raise Leadership